Our Blog

New hope for alopecia areata

07/12/16

The inflammatory molecules that cause alopecia areata are increasingly understood. Tofacitinib is a drug that was being tested for psoriasis and was observed to improve alopecia areata(AA). Formal clinical trials are now showing promising results. This drug could be a great help for many patients with severe AA who have previously had few options.

Read more

Biologic drugs for psoriasis

10/09/16

The NHS in England currently funds biologic drug treatments for the most severely affected psoriasis patients. The main risks are a very small increased risk of infection . Many patients get an excellent life changing response

Read more